AR and ductal breast carcinoma in situ: AR is also an important prognostic indicator and studies have shown that ductal carcinoma in situ of the breast with negative AR expression has a worse prognosis and a higher recurrence rate (Lee et al. 2020; Anestis et al. 2020).